EUR 0.31
(-27.91%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 671 Thousand EUR | 67099900.0% |
2022 | 1.00 EUR | 0.0% |
2021 | - EUR | 0.0% |
2020 | - EUR | -100.0% |
2019 | 386 Thousand EUR | -72.35% |
2018 | 1.39 Million EUR | 693.18% |
2017 | 176 Thousand EUR | 21.38% |
2016 | 145 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - EUR | -100.0% |
2024 Q2 | 946 Thousand EUR | 0.0% |
2023 Q4 | 671 Thousand EUR | 0.0% |
2023 Q3 | - EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2023 FY | - EUR | -100.0% |
2023 Q1 | - EUR | -100.0% |
2022 Q2 | - EUR | 0.0% |
2022 Q3 | - EUR | 0.0% |
2022 Q4 | 1.00 EUR | 0.0% |
2021 Q2 | - EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
2020 Q4 | - EUR | 0.0% |
2020 Q2 | 386 Thousand EUR | 0.0% |
2019 Q4 | 386 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Nicox S.A. | - EUR | -Infinity% |
European Medical Solutions | 14.35 Million EUR | 95.327% |
FERMENTALG | 6.8 Million EUR | 90.141% |
argenx SE | 281.12 Million EUR | 99.761% |
BioSenic S.A. | - EUR | -Infinity% |
Celyad Oncology SA | 1.26 Million EUR | 46.746% |
Hyloris Pharmaceuticals SA | 1.00 EUR | -67099900.0% |
Onward Medical N.V. | 936 Thousand EUR | 28.312% |
Oxurion NV | 128 Thousand EUR | -424.219% |
Financière de Tubize SA | - EUR | -Infinity% |
UCB SA | 1.03 Billion EUR | 99.935% |